Back
Ligand Pharmaceuticals, Inc. 10K Form
Sell
47
LGND
Ligand Pharmaceuticals, Inc.
Last Price:
$200.02
Seasonality Move:
4.34%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-08 | 10Q | LGND/Ligand Pharmaceuticals, Inc. Quarterly |
| 2023-11-09 | 10Q | LGND/Ligand Pharmaceuticals, Inc. Quarterly |
| 2023-08-09 | 10Q | LGND/Ligand Pharmaceuticals, Inc. Quarterly |
| 2023-05-08 | 10Q | LGND/Ligand Pharmaceuticals, Inc. Quarterly |
| 2022-11-08 | 10Q | LGND/Ligand Pharmaceuticals, Inc. Quarterly |
| 2022-08-09 | 10Q | LGND/Ligand Pharmaceuticals, Inc. Quarterly |
Receive LGND News And Ratings
See the #1 stock for the next 7 days that we like better than LGND
LGND Financial Statistics
Sales & Book Value
| Annual Sales: | $268.1M |
|---|---|
| Cash Flow: | $45.3M |
| Price / Cash Flow: | 106.26 |
| Annual Sales: | $51.44 |
| Price / Book: | 3.92 |
Profitability
| EPS (TTM): | 5.83470 |
|---|---|
| Net Income (TTM): | $124.5M |
| Gross Margin: | $220.8M |
| Return on Equity: | 14.07% |
| Return on Assets: | 10.67% |
Ligand Pharmaceuticals, Inc. Earnings Forecast
Key Ligand Pharmaceuticals, Inc. Financial Ratios
-
The Gross Profit Margin over the past 34 years for LGND is 82.37%.
-
The Selling, General & Administrative Expenses for LGND have been equal to 34.48% of Gross Profit Margin.
-
The Research & Development expenses have been 30.28% of Revenue.
-
The Interest Expense is 3.79% of Operating Income.
-
The Net Earning history of LGND is 46.42% of Total Revenues.
-
Per Share Earnings over the last 34 years have been positive in 19 years.
Ligand Pharmaceuticals, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | LGND |
| CUSIP: | 53220K |
| Website: | ligand.com |
Debt
| Debt-to-Equity Ratio: | 0.44 |
|---|---|
| Current Ratio: | 22.23 |
| Quick Ratio: | 21.18 |
Price-to-Earnings
| Trailing P/E Ratio: | 32.6 |
|---|---|
| Forward P/E Ratio: | 20.2 |
LGND Technical Analysis vs Fundamental Analysis
Sell
47
Ligand Pharmaceuticals, Inc. (LGND)
is a Sell
Is Ligand Pharmaceuticals, Inc. a Buy or a Sell?
-
Ligand Pharmaceuticals, Inc. stock is rated a SellThe current Ligand Pharmaceuticals, Inc. [LGND] share price is $199.93. The Score for LGND is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.